E/11 :  Dr. Hong Tang

A Journey from Chinese Traditional Medicine to The New Frontier of Biotech (July 1, 2021)

New frontiers in US-China biotech – Current geopolitical rhetoric notwithstanding, East-West scientific collaborations have typically resulted in breakthroughs that benefit all of humanity. The brilliant and compassionate Dr. Hong Tang is the CMO and co-founder of OnQuality Pharmaceuticals, a targeted cancer supportive care company developing medications to address specific side effects and improve the quality of life for patients receiving anti-cancer medications. In this episode, she talks of latest trends in immuno-oncology, US-China biotech, and how she draws upon her foundations in Traditional Chinese Medicine to combine its holistic philosophy with the rigour of her subsequent training in Western medicine.
Hong Tang Focuses on Innovation and Leveraging Her Native Country’s Booming Biotech Capabilities

Leave a Comment